STOCK TITAN
  1. Home
  2. PBAX

PBAX (PBAX) Stock Price, News & Analysis

PBAX NASDAQ

Company Description

This page collects what Stock Titan holds for PBAX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
-
-
Last updated:
-
Performance 1 year
-
Market Cap
-
Shares outstanding

Latest News

View All
-100.00%

Phoenix Biotech Acquisition Corp. and CERo Therapeutics, Inc. Announce Close of Business Combination

acquisition
0.00%

CERo Therapeutics, Inc. and Phoenix Biotech Acquisition Corp. Announce Merger Agreement to Create Public Company Advancing the Development of Next Generation Engineered T Cell Therapeutics

acquisition
—

Phoenix Biotech Acquisition Corp. Class A Common Shares and Warrants to Commence Trading Separately on November 26, 2021

acquisition
—

Phoenix Biotech Acquisition Corp. Announces Completion of $175,000,000 Initial Public Offering, Including Exercise of Over-Allotment Option

IPO offering acquisition
—

Phoenix Biotech Acquisition Corp. Announces Pricing of $155,000,000 Initial Public Offering

IPO offering acquisition

PBAX has 5 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition, IPO, offering. View all PBAX news →

SEC Filings

View All

No SEC filings available for PBAX.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months